GET THE APP

Development of RP-HPLC method for estimation of Olmesartan Medoxomil in tablet dosage forms | Abstract

Der Pharma Chemica
Journal for Medicinal Chemistry, Pharmaceutical Chemistry, Pharmaceutical Sciences and Computational Chemistry

ISSN: 0975-413X
All submissions of the EM system will be redirected to Online Manuscript Submission System. Authors are requested to submit articles directly to Online Manuscript Submission Systemof respective journal.

Abstract

Development of RP-HPLC method for estimation of Olmesartan Medoxomil in tablet dosage forms

Author(s): Chaitanya prasad MK, Vidyasagar G, Sambasiva Rao KRS and Ramanjeneyulu S

Reversed phase high performance liquid chromatographic method was developed and validated for the estimation of Olmesartan medoxomil in bulk and formulation. Selected mobile phase was a combination of phosphate buffer with pH adjusted at 2.8 and acetonitrile (35:65% v/v) and wavelength selected was 250 nm. Retention time of Olmesartan medoxomil was 2.591 min. Linearity of the method was found to be 50-150 μg/ml, with the regression coefficient of 0.9993. Quantification was done by calculating area of the peak and the detection limit and quantitation limit ware 0.02μg/mL and 0.09μg/mL, respectively. There was no significant difference in the intraday and inter day analysis of Olmesartan medoxomil determined for three different concentrations using this method. Present method can be applied for the determination of Olmesartan medoxomil in quality control of formulation without interference of the excipients.


PDF

Select your language of interest to view the total content in your interested language

30+ Million Readerbase
SCImago Journal & Country Rank
Google Scholar citation report
Citations : 25868

Der Pharma Chemica received 25868 citations as per Google Scholar report

Der Pharma Chemica peer review process verified at publons
Der Pharma Chemica- Journals on pharmaceutical chemistry